Health care workforce needs and Kaiser Permanente’s approach
download as a PDF The challenge Health care workforce needs To meet the health care needs of the future, the…
Health care workforce needs and Kaiser Permanente’s approach: leading with our values
The challenge Health care workforce needs To meet the health care needs of the future, the nation needs more health…
Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing
As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is…
How pharmaceutical marketing affects decisions about patient care
As we search for ways to improve the value of prescription drugs and make them more affordable, pharmaceutical marketing poses…
Drug policy 101: Pharmaceutical marketing tactics
Pharmaceutical marketing aims to shape both patient and clinician perceptions about a drug’s benefit and can significantly impact patient and…
Drug policy 101: Breaking down different types of drug products
As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is…
Drug policy 101: The state of the pharmaceutical evidence base
Having sound evidence about a drug’s safety and effectiveness is critical to understanding its benefits and value. In recent years,…
Drug policy 101: Drug patents
As drug prices continue rising unsustainably in the United States, patients and payers need to understand — and policy makers…
Drug policy 101: Biosimilars
Biologics — drugs derived from living organisms that are used to treat conditions such as rheumatoid arthritis, multiple sclerosis, and…
Drug policy 101: FDA risk evaluation and mitigation strategy (REMS)
Over the past couple of decades, pharmaceutical innovation has provided many new treatments for diseases that previously had limited therapeutic…
